N-(3-bromoimidazo[1,2-a]pyridin-2-yl)-N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-4-pyrazol-1-ylbenzenesulfonamide

C24H16BrF4N5O2S — CID 57377299

IUPACN-(3-bromoimidazo[1,2-a]pyridin-2-yl)-N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-4-pyrazol-1-ylbenzenesulfonamide
SMILESO=S(=O)(c1ccc(-n2cccn2)cc1)N(Cc1ccc(F)c(C(F)(F)F)c1)c1nc2ccccn2c1Br
InChIInChI=1S/C24H16BrF4N5O2S/c25-22-23(31-21-4-1-2-12-32(21)22)34(15-16-5-10-20(26)19(14-16)24(27,28)29)37(35,36)18-8-6-17(7-9-18)33-13-3-11-30-33/h1-14H,15H2
InChIKeyFNLMCXQJDKAPKY-UHFFFAOYSA-N
MW594.39 g/mol
LogP5.84
Rot. Bonds6

About N-(3-bromoimidazo[1,2-a]pyridin-2-yl)-N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-4-pyrazol-1-ylbenzenesulfonamide

N-(3-bromoimidazo[1,2-a]pyridin-2-yl)-N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-4-pyrazol-1-ylbenzenesulfonamide (PubChem CID 57377299) has the molecular formula C24H16BrF4N5O2S and a molecular weight of 594.39 g/mol. Its IUPAC name is N-(3-bromoimidazo[1,2-a]pyridin-2-yl)-N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-4-pyrazol-1-ylbenzenesulfonamide.

Molecular Properties

Compound NameN-(3-bromoimidazo[1,2-a]pyridin-2-yl)-N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-4-pyrazol-1-ylbenzenesulfonamide
PubChem CID57377299
Molecular FormulaC24H16BrF4N5O2S
Molecular Weight594.39 g/mol
Exact Mass593.01
IUPAC NameN-(3-bromoimidazo[1,2-a]pyridin-2-yl)-N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-4-pyrazol-1-ylbenzenesulfonamide
SMILESO=S(=O)(c1ccc(-n2cccn2)cc1)N(Cc1ccc(F)c(C(F)(F)F)c1)c1nc2ccccn2c1Br
InChIInChI=1S/C24H16BrF4N5O2S/c25-22-23(31-21-4-1-2-12-32(21)22)34(15-16-5-10-20(26)19(14-16)24(27,28)29)37(35,36)18-8-6-17(7-9-18)33-13-3-11-30-33/h1-14H,15H2
InChIKeyFNLMCXQJDKAPKY-UHFFFAOYSA-N
XLogP5.84
TPSA72.50 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms37
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500594.39
LogP ≤ 55.84
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze N-(3-bromoimidazo[1,2-a]pyridin-2-yl)-N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-4-pyrazol-1-ylbenzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(3-bromoimidazo[1,2-a]pyridin-2-yl)-N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-4-pyrazol-1-ylbenzenesulfonamide?
The IUPAC name of N-(3-bromoimidazo[1,2-a]pyridin-2-yl)-N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-4-pyrazol-1-ylbenzenesulfonamide (CID 57377299) is N-(3-bromoimidazo[1,2-a]pyridin-2-yl)-N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-4-pyrazol-1-ylbenzenesulfonamide.
What is the SMILES notation for N-(3-bromoimidazo[1,2-a]pyridin-2-yl)-N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-4-pyrazol-1-ylbenzenesulfonamide?
The canonical SMILES for N-(3-bromoimidazo[1,2-a]pyridin-2-yl)-N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-4-pyrazol-1-ylbenzenesulfonamide is O=S(=O)(c1ccc(-n2cccn2)cc1)N(Cc1ccc(F)c(C(F)(F)F)c1)c1nc2ccccn2c1Br.
What is the InChIKey of N-(3-bromoimidazo[1,2-a]pyridin-2-yl)-N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-4-pyrazol-1-ylbenzenesulfonamide?
The InChIKey is FNLMCXQJDKAPKY-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H16BrF4N5O2S/c25-22-23(31-21-4-1-2-12-32(21)22)34(15-16-5-10-20(26)19(14-16)24(27,28)29)37(35,36)18-8-6-17(7-9-18)33-13-3-11-30-33/h1-14H,15H2.
What are the key properties of N-(3-bromoimidazo[1,2-a]pyridin-2-yl)-N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-4-pyrazol-1-ylbenzenesulfonamide?
N-(3-bromoimidazo[1,2-a]pyridin-2-yl)-N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-4-pyrazol-1-ylbenzenesulfonamide has a molecular weight of 594.39 g/mol, XLogP of 5.84, 6 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-(3-bromoimidazo[1,2-a]pyridin-2-yl)-N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-4-pyrazol-1-ylbenzenesulfonamide is sourced from PubChem (CID 57377299), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).